Weight gain with tumour necrosis factor-α inhibitors

被引：1
|
作者：
Stamp, L [1 ]
Cross, N
O'Donnell, J
机构：
[1] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand
[2] Christchurch Publ Hlth, Dept Rheumatol, Christchurch, New Zealand
[3] Christchurch Publ Hlth, Dept Clin Pharmacol, Christchurch, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2005年 / 35卷 / 04期
关键词：
D O I：
10.1111/j.1445-5994.2005.00809.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [11] Tumour necrosis factor-α inhibitors/immunosuppressantsCancer: 3 case reports
    Reactions Weekly, 2012, 1423 (1) : 48 - 48
  • [12] EXPRESSION OF TUMOUR NECROSIS FACTOR-α CONVERTING ENZYME AND TUMOUR NECROSIS FACTOR-α IN RATS WITH ALCOHOLIC CARDIOMYOPATHY
    Li Jianqiang
    Li Weimin
    Li Yue
    Zhao Jiyi
    Kong Yihui
    Guo Hong
    Xue Jingyi
    Sheng Li
    Gong Yongtai
    Xue Hongjie
    HEART, 2010, 96 : A49 - A50
  • [13] Ustekinumab in the treatment of psoriasis in patients resistant to tumour necrosis factor-α inhibitors
    O'Shea, S. J.
    Rogers, S.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 444 - 444
  • [14] Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis
    Nilsson, Anna Christine
    Christensen, Anne Friesgaard
    Junker, Peter
    Lindegaard, Hanne Merete
    DANISH MEDICAL BULLETIN, 2011, 58 (04)
  • [15] Tumour necrosis factor inhibitors
    Hill, Catherine L.
    Nash, Peter
    AUSTRALIAN PRESCRIBER, 2008, 31 (03) : 61 - 61
  • [16] Tumour necrosis factor inhibitors
    Nash, PT
    Florin, THJ
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 183 (04) : 205 - 208
  • [17] Endometriosis is sustained by tumour necrosis factor-α
    Bullimore, DW
    MEDICAL HYPOTHESES, 2003, 60 (01) : 84 - 88
  • [18] Safety of tumour necrosis factor-α antagonists
    Khanna, D
    McMahon, M
    Furst, DE
    DRUG SAFETY, 2004, 27 (05) : 307 - 324
  • [19] Safety of Tumour Necrosis Factor-α Antagonists
    Dinesh Khanna
    Maureen McMahon
    Daniel E. Furst
    Drug Safety, 2004, 27 : 307 - 324
  • [20] Tumour necrosis factor-α inhibitors/methotrexateCutaneous and visceral leishmaniasis: 6 case reports
    Reactions Weekly, 2018, 1723 (1) : 287 - 287
12345